Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

Market Cap	4.08B
Revenue (ttm)	294.94M
Net Income (ttm)	88.07M
Shares Out	66.17M
EPS (ttm)	1.33
PE Ratio	46.43
Forward PE	n/a
Dividend	0.60 (0.99%)
Ex-Dividend Date	May 30, 2025

Volume	776,000
Average Volume	1,227,677
Open	61.18
Previous Close	60.92
Day's Range	59.90 - 61.30
52-Week Range	36.88 - 69.80
Beta	-0.04
RSI	50.58
Earnings Date	Aug 22, 2025

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301033

Financial Performance

In 2024, SHE:301033's revenue was 278.44 million, an increase of 20.61% compared to the previous year's 230.87 million. Earnings were 78.85 million, an increase of 92.90%.